azacitidine and laq824

azacitidine has been researched along with laq824 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Hurtubise, A; Momparler, RL1
Atadja, P; Bhalla, K; Chen, J; Eaton, K; Fernandez, P; Fiskus, W; Herger, B; Joshi, R; Kolhe, R; Lee, P; Mandawat, A; Peiper, S; Rao, R; Wang, Y; Yang, Y1
Berchmans, E; Dubovsky, JA; Pinilla-Ibarz, JA; Powers, JJ; Smith, MA; Sotomayor, EM; Wang, D; Wright, KL1

Other Studies

4 other study(ies) available for azacitidine and laq824

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Effect of histone deacetylase inhibitor LAQ824 on antineoplastic action of 5-Aza-2'-deoxycytidine (decitabine) on human breast carcinoma cells.
    Cancer chemotherapy and pharmacology, 2006, Volume: 58, Issue:5

    Topics: Antimetabolites, Antineoplastic; Azacitidine; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Colony-Forming Units Assay; Decitabine; DNA; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Female; Flow Cytometry; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Inhibitory Concentration 50; Neoplastic Stem Cells; S Phase; Time Factors

2006
Molecular and biologic characterization and drug sensitivity of pan-histone deacetylase inhibitor-resistant acute myeloid leukemia cells.
    Blood, 2008, Oct-01, Volume: 112, Issue:7

    Topics: Acetylation; Animals; Antineoplastic Agents; Apoptosis; Azacitidine; Benzoquinones; Cell Differentiation; Cell Proliferation; Decitabine; DNA-Binding Proteins; Drug Resistance, Neoplasm; Enzyme Inhibitors; Heat Shock Transcription Factors; Histone Deacetylase Inhibitors; HL-60 Cells; HSP70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Humans; Hydroxamic Acids; Indoles; Lactams, Macrocyclic; Leukemia, Myeloid, Acute; Mice; Mice, Inbred NOD; Neoplasm Proteins; Panobinostat; S Phase; Transcription Factors; Tubulin; Vorinostat

2008
Restoring the functional immunogenicity of chronic lymphocytic leukemia using epigenetic modifiers.
    Leukemia research, 2011, Volume: 35, Issue:3

    Topics: Acetylation; Antigens, Neoplasm; Antimetabolites, Antineoplastic; Azacitidine; Decitabine; DNA Methylation; Drug Synergism; Epigenomics; Histones; Humans; Hydroxamic Acids; Immunophenotyping; L-Lactate Dehydrogenase; Leukemia, Lymphocytic, Chronic, B-Cell; Male; T-Lymphocytes; Testis; Th1 Cells; Tumor Cells, Cultured

2011